125 related articles for article (PubMed ID: 12057837)
1. Mouse model of optic neuropathy caused by mitochondrial complex I dysfunction.
Zhang X; Jones D; Gonzalez-Lima F
Neurosci Lett; 2002 Jun; 326(2):97-100. PubMed ID: 12057837
[TBL] [Abstract][Full Text] [Related]
2. Neurodegeneration produced by rotenone in the mouse retina: a potential model to investigate environmental pesticide contributions to neurodegenerative diseases.
Zhang X; Jones D; Gonzalez-Lima F
J Toxicol Environ Health A; 2006 Sep; 69(18):1681-97. PubMed ID: 16864419
[TBL] [Abstract][Full Text] [Related]
3. Methylene blue prevents neurodegeneration caused by rotenone in the retina.
Zhang X; Rojas JC; Gonzalez-Lima F
Neurotox Res; 2006 Jan; 9(1):47-57. PubMed ID: 16464752
[TBL] [Abstract][Full Text] [Related]
4. The metabolomic signature of Leber's hereditary optic neuropathy reveals endoplasmic reticulum stress.
Chao de la Barca JM; Simard G; Amati-Bonneau P; Safiedeen Z; Prunier-Mirebeau D; Chupin S; Gadras C; Tessier L; Gueguen N; Chevrollier A; Desquiret-Dumas V; Ferré M; Bris C; Kouassi Nzoughet J; Bocca C; Leruez S; Verny C; Miléa D; Bonneau D; Lenaers G; Martinez MC; Procaccio V; Reynier P
Brain; 2016 Nov; 139(11):2864-2876. PubMed ID: 27633772
[TBL] [Abstract][Full Text] [Related]
5. Progressive optic atrophy in a retinal ganglion cell-specific mouse model of complex I deficiency.
Wang L; Klingeborn M; Travis AM; Hao Y; Arshavsky VY; Gospe SM
Sci Rep; 2020 Oct; 10(1):16326. PubMed ID: 33004958
[TBL] [Abstract][Full Text] [Related]
6. Optic neuropathy induced by reductions in mitochondrial superoxide dismutase.
Qi X; Lewin AS; Hauswirth WW; Guy J
Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1088-96. PubMed ID: 12601034
[TBL] [Abstract][Full Text] [Related]
7. Optic neuropathies--importance of spatial distribution of mitochondria as well as function.
Yu Wai Man CY; Chinnery PF; Griffiths PG
Med Hypotheses; 2005; 65(6):1038-42. PubMed ID: 16098682
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume.
Otmani A; Jóhannesson G; Brautaset R; Tribble JR; Williams PA
Acta Neuropathol Commun; 2024 Mar; 12(1):37. PubMed ID: 38429841
[TBL] [Abstract][Full Text] [Related]
9. Acquired mitochondrial impairment as a cause of optic nerve disease.
Sadun A
Trans Am Ophthalmol Soc; 1998; 96():881-923. PubMed ID: 10360310
[TBL] [Abstract][Full Text] [Related]
10. Rescue of cell death and inflammation of a mouse model of complex 1-mediated vision loss by repurposed drug molecules.
Yu AK; Datta S; McMackin MZ; Cortopassi GA
Hum Mol Genet; 2017 Dec; 26(24):4929-4936. PubMed ID: 29040550
[TBL] [Abstract][Full Text] [Related]
11. A defect in mitochondrial electron-transport activity (NADH-coenzyme Q oxidoreductase) in Leber's hereditary optic neuropathy.
Parker WD; Oley CA; Parks JK
N Engl J Med; 1989 May; 320(20):1331-3. PubMed ID: 2497346
[No Abstract] [Full Text] [Related]
12. Bipolar cell reduction precedes retinal ganglion neuron loss in a complex 1 knockout mouse model.
Song L; Yu A; Murray K; Cortopassi G
Brain Res; 2017 Feb; 1657():232-244. PubMed ID: 28027875
[TBL] [Abstract][Full Text] [Related]
13. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies.
Lopez Sanchez MI; Crowston JG; Mackey DA; Trounce IA
Pharmacol Ther; 2016 Sep; 165():132-52. PubMed ID: 27288727
[TBL] [Abstract][Full Text] [Related]
14. Melanopsin-expressing retinal ganglion cells are resistant to cell injury, but not always.
Georg B; Ghelli A; Giordano C; Ross-Cisneros FN; Sadun AA; Carelli V; Hannibal J; La Morgia C
Mitochondrion; 2017 Sep; 36():77-84. PubMed ID: 28412540
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of memantine in a mouse model of retinal degeneration induced by rotenone.
Rojas JC; Saavedra JA; Gonzalez-Lima F
Brain Res; 2008 Jun; 1215():208-17. PubMed ID: 18486118
[TBL] [Abstract][Full Text] [Related]
16. Methylene blue provides behavioral and metabolic neuroprotection against optic neuropathy.
Rojas JC; John JM; Lee J; Gonzalez-Lima F
Neurotox Res; 2009 Apr; 15(3):260-73. PubMed ID: 19384599
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction affecting visual pathways.
Leruez S; Amati-Bonneau P; Verny C; Reynier P; Procaccio V; Bonneau D; Milea D
Rev Neurol (Paris); 2014 May; 170(5):344-54. PubMed ID: 24798923
[TBL] [Abstract][Full Text] [Related]
18. Electroretinographical and histological study of mouse retina after optic nerve section: a comparison between wild-type and retinal degeneration 1 mice.
Germain F; Istillarte M; Gómez-Vicente V; Pérez-Rico C; de la Villa P
Clin Exp Ophthalmol; 2013 Aug; 41(6):593-602. PubMed ID: 23279351
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies.
Lee S; Van Bergen NJ; Kong GY; Chrysostomou V; Waugh HS; O'Neill EC; Crowston JG; Trounce IA
Exp Eye Res; 2011 Aug; 93(2):204-12. PubMed ID: 20691180
[TBL] [Abstract][Full Text] [Related]
20. Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON).
Beretta S; Wood JP; Derham B; Sala G; Tremolizzo L; Ferrarese C; Osborne NN
Neurobiol Dis; 2006 Nov; 24(2):308-17. PubMed ID: 16959493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
